Gregory P. Madison
2016
In 2016, Gregory P. Madison earned a total compensation of $2M as Chief Executive Officer and President at Keryx Biopharmaceuticals, a 68% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $243,337 |
|---|---|
| Option Awards | $720,165 |
| Salary | $539,054 |
| Stock Awards | $515,063 |
| Other | $680 |
| Total | $2,018,299 |
Madison received $720.2K in option awards, accounting for 36% of the total pay in 2016.
Madison also received $243.3K in non-equity incentive plan, $539.1K in salary, $515.1K in stock awards and $680 in other compensation.
Rankings
In 2016, Gregory P. Madison's compensation ranked 4,843rd out of 14,075 executives tracked by ExecPay. In other words, Madison earned more than 65.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,843 out of 14,075 | 66th |
Division Manufacturing | 1,725 out of 5,486 | 69th |
Major group Chemicals And Allied Products | 538 out of 1,900 | 72nd |
Industry group Drugs | 397 out of 1,543 | 74th |
Industry Pharmaceutical Preparations | 315 out of 1,173 | 73rd |
Source: SEC filing on April 26, 2017.
Madison's colleagues
We found three more compensation records of executives who worked with Gregory P. Madison at Keryx Biopharmaceuticals in 2016.